A Phase I/II Study of T Cell Receptor Gene Therapy Targeting HPV-16 E6 for HPV-Associated Cancers
Phase of Trial: Phase I/II
Latest Information Update: 09 Aug 2017
At a glance
- Drugs E6 TCR (Primary) ; Aldesleukin; Cyclophosphamide; Fludarabine
- Indications Anal cancer; Cancer; Cervical cancer; Oropharyngeal cancer; Penile cancer; Vulvovaginal cancer
- Focus Adverse reactions; Therapeutic Use
- 06 Jun 2017 Results presented at the 53rd Annual Meeting of the American Society of Clinical Oncology.
- 29 Jun 2016 Status changed from active, no longer recruiting to completed.
- 20 May 2016 Status changed from suspended to active, no longer recruiting.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History